BIO3 — Biotest AG Income Statement
0.000.00%
Last trade - 00:00HealthcareConservativeMid CapNeutral
- €1.33bn
- €1.80bn
- €515.60m
- 44
- 19
- 61
- 33
Annual income statement for Biotest AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 378 | 400 | 419 | 484 | 516 |
| Cost of Revenue | |||||
| Gross Profit | 134 | 135 | 129 | 130 | 80.7 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 387 | 390 | 420 | 486 | 563 |
| Operating Profit | -9.3 | 10.6 | -1.2 | -1.3 | -47.1 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -26 | -6 | -1.3 | -30 | -62.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -16.4 | -12.9 | -4.7 | -31.4 | -63.3 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -3.5 | 182 | -4.7 | -31.4 | -63.3 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -3.9 | 181 | -4.81 | -32.2 | -65 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.252 | -0.3 | -0.076 | -0.83 | -3.39 |
| Dividends per Share |